MOTS-C 10mg
- 01Reconstitution solution
- 1 mL
- 02Dose
- 1 mg
- 03Syringe units
- 10 units
- 04Frequency
- 7x/week
- 05Cycle length
- 90 days
- 06Bacteriostatic water
- 1 mL
- 07Bottle size
- 10 mg
- 08Bottles needed
- 9
A 16-amino-acid peptide encoded in mitochondrial DNA that acts as an exercise-mimetic metabolic regulator in mice. Human data is observational only.
MOTS-c is encoded inside mitochondrial DNA and released into circulation, where it acts as a signal to the rest of the body. When the cell is under metabolic stress it moves into the nucleus and changes which genes are switched on — a mitochondrial peptide directly instructing the nuclear genome. In mice it improves insulin sensitivity, prevents diet-induced obesity and improves physical performance in old animals. In humans, levels have been measured and correlate with exercise and metabolic health, but nobody has been given it in a trial.
A 16-amino-acid peptide encoded in the mitochondrial 12S rRNA gene MT-RNR1. Under metabolic stress it translocates to the nucleus and regulates adaptive nuclear gene expression through ATF1 and antioxidant response elements. Activates AMPK, increases GLUT4 translocation and shifts folate-methionine cycle flux, reducing purine biosynthesis. In mice, administration prevents diet-induced obesity and insulin resistance and improves physical capacity in aged animals. Human plasma levels rise acutely with exercise and are lower in insulin-resistant states. A common East Asian mitochondrial variant, m.1382A>C, alters the MOTS-c sequence and has been associated with longevity in Japanese cohorts.
Research areas
Community-specified data
Source note: Standard protocol — large bottle
Not medical guidance. These third-party figures have not been independently verified, clinically reviewed, or endorsed by DB Peptide. They may be inaccurate or unsafe and should not replace product labelling or advice from a qualified clinician.
Every protocol below is reproduced from a published study or approved labelling, with its source named. These are records of what was studied — not recommendations, and not a suggestion that any of them is appropriate for any person.
| Protocol as reported | Source |
|---|---|
| Intraperitoneal MOTS-c in high-fat-diet mice with insulin sensitivity and body composition endpoints | Lee et al., Cell Metabolism 2015 |
| Late-life intraperitoneal MOTS-c in aged mice with physical capacity endpoints | Reynolds et al., Nature Communications 2021 |
Observational human studies of endogenous levels. No interventional human trials.
It is exercise-responsive — levels rise after exercise — and giving it to mice reproduces some metabolic adaptations. That is not the same as replacing exercise in a human, and no human has received it in a controlled study.
The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance
MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis
Naturally occurring mitochondrial-derived peptides are age-dependent regulators of apoptosis, insulin sensitivity, and inflammatory markers
Medical disclaimer
This page is for informational and research purposes only. Nothing here constitutes medical advice. The compounds discussed are research chemicals. Consult a qualified clinician before starting any protocol.
How this profile was built →